Searched for: in-biosketch:true
person:tanejs01
Imaging Facilities' Adherence to PI-RADS v2 Minimum Technical Standards for the Performance of Prostate MRI
Esses, Steven J; Taneja, Samir S; Rosenkrantz, Andrew B
PURPOSE: This study aimed to assess variability in imaging facilities' adherence to the minimum technical standards for prostate magnetic resonance imaging acquisition established by Prostate Imaging-Reporting and Data System (PI-RADS) version 2 (v2). METHODS: A total of 107 prostate magnetic resonance imaging examinations performed at 107 unique imaging facilities after the release of PI-RADS v2 and that were referred to a tertiary care center for secondary interpretation were included. Image sets, DICOM headers, and outside reports were reviewed to assess adherence to 21 selected PI-RADS v2 minimum technical standards. RESULTS: Hardware arrangements were 23.1%, 1.5T without endorectal coil; 7.7%, 1.5T with endorectal coil; 63.5%, 3T without endorectal coil; and 5.8%, 3T with endorectal coil. Adherence to minimum standards was lowest on T2 weighted imaging (T2WI) for frequency resolution =0.4 mm (16.8%) and phase resolution =0.7 mm (48.6%), lowest on diffusion-weighted imaging (DWI) for field of view (FOV) 120-220 mm (30.0%), and lowest on dynamic contrast-enhanced (DCE) imaging for slice thickness 3 mm (33.3%) and temporal resolution <10 s (31.5%). High b-value (>/=1400 s/mm2) images were included in 58.0% (calculated in 25.9%). Adherence to T2WI phase resolution and DWI inter-slice gap were greater (P < .05) at 3T than at 1.5T. Adherence did not differ (P > .05) for any parameter between examinations performed with and without an endorectal coil. Adherence was greater for examinations performed at teaching facilities for T2WI slice thickness and DCE temporal resolution (P < .05). Adherence was not better for examinations performed in 2016 than in 2015 for any parameter (P > .05). CONCLUSION: Facilities' adherence to PI-RADS v2 minimum technical standards was variable, being particularly poor for T2WI frequency resolution and DCE temporal resolution. The standards warrant greater community education. Certain technical standards may be too stringent, and revisions should be considered.
PMID: 29107458
ISSN: 1878-4046
CID: 2773212
Reply
Bjurlin, Marc A; Rosenkrantz, Andrew B; Taneja, Samir S
PMID: 29290416
ISSN: 1527-9995
CID: 2899662
Re: Follow-up of Prostatectomy versus Observation for Early Prostate Cancer
Taneja, Samir S
PMID: 29357561
ISSN: 1527-3792
CID: 2988532
Re: Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group
Taneja, Samir S
PMID: 29357562
ISSN: 1527-3792
CID: 2988542
Re-Creating the Urinary Tract: An Art Derived from Science [Editorial]
Taneja, Samir S
PMID: 29169455
ISSN: 1558-318x
CID: 2792132
Re: Surrogate End Points for All-Cause Mortality in Men with Localized Unfavorable-Risk Prostate Cancer Treated with Radiation Therapy vs Radiation Therapy plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial
Taneja, Samir S
PMID: 29310183
ISSN: 1527-3792
CID: 2987662
Apparent Diffusion Coefficient Values of Prostate Cancer: Comparison of 2D and 3D ROIs
Tamada, Tsutomu; Huang, Chenchan; Ream, Justin M; Taffel, Myles; Taneja, Samir S; Rosenkrantz, Andrew B
OBJECTIVE: The purpose of this study was to compare the reproducibility and diagnostic performance of 2D and 3D ROIs for prostate apparent diffusion coefficient (ADC) measurements. MATERIALS AND METHODS: The study included 56 patients with prostate cancer undergoing 3-T MRI including DWI (b = 50 and 1000 s/mm2) before radical prostatectomy. Histologic findings from prostatectomy specimens were reviewed to denote each patient's dominant tumor and a benign region with visually decreased ADC. Three readers independently measured the ADCs of both areas using an ROI placed on a single slice through the lesion (2D) and an ROI encompassing all slices through the lesion (3D). Readers repeated measurements after 3 weeks. Assessment included Bland-Altman analysis (coefficient of repeatability [CR] in which lower values indicated higher reliability) and ROC analysis. RESULTS: For intrareader variability, the CRs across readers for all ROIs were 9.9% for 2D and 9.3% for 3D. For tumor ROIs the CRs were 10.6% for 2D and 9.6% for 3D. For interreader variability, the CRs across readers for all ROIs were 17.1% for 2D and 20.5% for 3D and for tumor ROIs were 17.9% for 2D and 22.2% for 3D. For combined reader data, the AUCs for benign and malignant findings were 0.77 for 2D and 0.78 for 3D (p = 0.146). For differentiating Gleason score (GS) 3 + 3 from GS > 3 + 3 tumors, the AUCs were 0.92 for 2D and 0.92 for 3D ROIs (p = 0.649). For differentiating GS = 3 + 4 from GS >/= 4 + 3 tumors, the AUCs were 0.70 for 2D and 0.67 for 3D ROIs (p = 0.004). CONCLUSION: Use of a 3D ROI did not improve intrareader or interreader reproducibility or diagnostic performance compared with use of a 2D ROI for prostate ADC measurements. Interreader reproducibility of 2D ROIs was suboptimal nonetheless.
PMID: 29045185
ISSN: 1546-3141
CID: 2743082
A Comparison of Radiologists' and Urologists' Opinions Regarding Prostate MRI Reporting: Results From a Survey of Specialty Societies
Spilseth, Benjamin; Ghai, Sangeet; Patel, Nayana U; Taneja, Samir S; Margolis, Daniel J; Rosenkrantz, Andrew B
OBJECTIVE: The purpose of this study is to compare radiologists' and urologists' opinions regarding prostate MRI reporting. SUBJECTS AND METHODS: Radiologist members of the Society of Abdominal Radiology and urologist members of the Society of Urologic Oncology received an electronic survey regarding prostate MRI reporting. RESULTS: The response rate was 12% (135/1155) for Society of Abdominal Radiology and 8% (54/663) for Society of Urologic Oncology members. Most respondents in both specialties prefer Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) (radiologists, 84%; urologists, 84%), indicate that it is used at their institution (radiologists, 84%; urologists, 78%), understand its implications for patient care (radiologists, 89%; urologists, 71%), and agree that radiologists apply PI-RADSv2 categories correctly (radiologists, 57%; urologists, 61%). Both specialties agreed regarding major barriers to PI-RADSv2 adoption: radiologist inexperience using PI-RADSv2 (radiologists, 51%; urologists, 51%), urologist inexperience using PI-RADSv2 (radiologists, 46%; urologists, 51%), and lack of standardized templates (radiologists, 47%; urologists, 52%). The specialties disagreed (p = 0.039) regarding whether reports should include the following management recommendations: targeted biopsy (radiologists, 58%; urologists, 34%), follow-up imaging (radiologists, 46%; urologists, 28%), and time interval for follow-up imaging (radiologists, 35%; urologists, 16%). There was also disagreement (p = 0.037) regarding report style: 54% of urologists preferred fully structured reports, whereas 53% of radiologists preferred hybrid structured and free-text reports. CONCLUSION: Radiologists and urologists both strongly prefer PI-RADSv2 for prostate MRI reporting, despite recognizing barriers to its adoption. Urologists more strongly preferred a fully structured report and disagreed with radiologists' preference to include management recommendations. Collaborative radiologist-urologist educational efforts are warranted to help optimize the effect of prostate MRI reporting in patient care.
PMID: 29064758
ISSN: 1546-3141
CID: 2757402
Re: Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Taneja, Samir S
PMID: 29310181
ISSN: 1527-3792
CID: 2987652
HistoScanningTM to Detect and Characterize Prostate Cancer-a Review of Existing Literature
Wysock, J S; Xu, A; Orczyk, C; Taneja, S S
Purpose of Review: The widely acknowledged limitations of the standard prostate cancer (PCa) diagnostic paradigm have provided an impetus to explore novel imaging modalities to diagnose, localize, and risk stratify PCa. As the body of literature focused on HistoScanningTM(HS) grows, there is need for a comprehensive review of the clinical efficacy of this technology. Recent Findings: Eighteen original, English language articles were found to adequately study the use of HistoScanningTM for prostate cancer diagnosis in the clinical setting. The articles were found by conducting a bibliographic search of PubMed in April 2017 in addition to utilizing references. The studies are divided into four groups based on study design. Study methods and quantitative data are summarized for each of the relevant articles. The results are synthesized to evaluate the utility of HistoScanningTM for the purpose of diagnosing PCa. Summary: Despite the promise of early pilot studies, there is a lack of consistent results across a number of further investigations of HistoScanningTM. This becomes increasingly evident as study size increases. As various other modern diagnostic modalities continue to develop, the future of HistoScanningTM, both alone and in conjunction with these technologies, remains unclear.
EMBASE:618931400
ISSN: 1534-6285
CID: 2778142